These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influenza vaccination cost effective in U.S. adults. Geriatrics; 2006 Feb; 61(2):14. PubMed ID: 16502520 [No Abstract] [Full Text] [Related]
3. Cost-effectiveness of influenza vaccination in working-age cancer patients. Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827 [TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia. Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537 [TBL] [Abstract][Full Text] [Related]
5. [Cost-effectiveness analysis of antigrippal vaccination in a rural population (La Victoria, Cordoba)]. Gavira FJ; Lardinois R Med Clin (Barc); 1990 May; 94(20):777-81. PubMed ID: 2118204 [TBL] [Abstract][Full Text] [Related]
6. [Cost-effectiveness of prophylaxis and treatment of influenza]. Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642 [No Abstract] [Full Text] [Related]
7. Influenza vaccination: cost-effective health care for the older adult? Hampson AW; Irving LB J Qual Clin Pract; 1997 Mar; 17(1):3-11. PubMed ID: 9107599 [TBL] [Abstract][Full Text] [Related]
8. [Anti-influenza vaccination for active persons (25-64 years): a cost-benefit study]. Levy E; Levy P Rev Epidemiol Sante Publique; 1992; 40(5):285-95. PubMed ID: 1480805 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of universal influenza vaccination in a pregnant population. Roberts S; Hollier LM; Sheffield J; Laibl V; Wendel GD Obstet Gynecol; 2006 Jun; 107(6):1323-9. PubMed ID: 16738159 [TBL] [Abstract][Full Text] [Related]
10. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. Rothberg MB; Rose DN Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212 [TBL] [Abstract][Full Text] [Related]
12. Problems with influenza vaccine. Med Lett Drugs Ther; 2000 Sep; 42(1086):79-80. PubMed ID: 10980810 [No Abstract] [Full Text] [Related]
13. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain. Aballéa S; De Juanes JR; Barbieri M; Martin M; Chancellor J; Oyagüez I; Verwee B; Largeron N Vaccine; 2007 Sep; 25(39-40):6900-10. PubMed ID: 17764790 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851 [TBL] [Abstract][Full Text] [Related]